-
1
-
-
0036569654
-
Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer
-
10.1016/S0360-3016(01)02806-1, 12007953
-
Shinchi H, Takao S, Noma H, Matsuo Y, Mataki Y, Mori S, Aikou T. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2002, 53:146-150. 10.1016/S0360-3016(01)02806-1, 12007953.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 146-150
-
-
Shinchi, H.1
Takao, S.2
Noma, H.3
Matsuo, Y.4
Mataki, Y.5
Mori, S.6
Aikou, T.7
-
2
-
-
0019410935
-
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group
-
10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4, 7284971
-
Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO, Thomas P, Nave H, Bateman J, Lokich J, Brooks J, Chaffey J, Corson JM, Zamcheck N, Novak JW. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981, 48:1705-1710. 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4, 7284971.
-
(1981)
Cancer
, vol.48
, pp. 1705-1710
-
-
Moertel, C.G.1
Frytak, S.2
Hahn, R.G.3
O'Connell, M.J.4
Reitemeier, R.J.5
Rubin, J.6
Schutt, A.J.7
Weiland, L.H.8
Childs, D.S.9
Holbrook, M.A.10
Lavin, P.T.11
Livstone, E.12
Spiro, H.13
Knowlton, A.14
Kalser, M.15
Barkin, J.16
Lessner, H.17
Mann-Kaplan, R.18
Ramming, K.19
Douglas, H.O.20
Thomas, P.21
Nave, H.22
Bateman, J.23
Lokich, J.24
Brooks, J.25
Chaffey, J.26
Corson, J.M.27
Zamcheck, N.28
Novak, J.W.29
more..
-
3
-
-
0023722682
-
Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
-
Gastrointestinal Tumor Study Group
-
Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988, 80:751-755. Gastrointestinal Tumor Study Group.
-
(1988)
J Natl Cancer Inst
, vol.80
, pp. 751-755
-
-
-
4
-
-
34249790871
-
A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
-
10.1038/sj.bjc.6603788, 2359907, 17533388
-
Ikeda M, Okusaka T, Ito Y, Ueno H, Morizane C, Furuse J, Ishii H, Kawashima M, Kagami Y, Ikeda H. A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Br J Cancer 2007, 96:1650-1655. 10.1038/sj.bjc.6603788, 2359907, 17533388.
-
(2007)
Br J Cancer
, vol.96
, pp. 1650-1655
-
-
Ikeda, M.1
Okusaka, T.2
Ito, Y.3
Ueno, H.4
Morizane, C.5
Furuse, J.6
Ishii, H.7
Kawashima, M.8
Kagami, Y.9
Ikeda, H.10
-
5
-
-
0029835349
-
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators
-
10.1097/00001813-199607000-00010, 8862723
-
Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, Fukushima M. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 1996, 7:548-557. 10.1097/00001813-199607000-00010, 8862723.
-
(1996)
Anticancer Drugs
, vol.7
, pp. 548-557
-
-
Shirasaka, T.1
Shimamato, Y.2
Ohshimo, H.3
Yamaguchi, M.4
Kato, T.5
Yonekura, K.6
Fukushima, M.7
-
6
-
-
58249132914
-
Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
-
10.1007/s00280-008-0836-1, 18828020
-
Kim HM, Bang S, Park JY, Seong J, Song SY, Chung JB, Park SW. Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer. Cancer Chemother Pharmacol 2009, 63:535-541. 10.1007/s00280-008-0836-1, 18828020.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 535-541
-
-
Kim, H.M.1
Bang, S.2
Park, J.Y.3
Seong, J.4
Song, S.Y.5
Chung, J.B.6
Park, S.W.7
-
7
-
-
79954425756
-
Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer
-
10.1016/j.ijrobp.2010.01.027, 20605363
-
Sudo K, Yamaguchi T, Ishihara T, Nakamura K, Hara T, Denda T, Tawada K, Imagumbai T, Araki H, Sakai M, Hatano K, Kawakami H, Uno T, Ito H, Yokosuka O. Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2011, 80:119-125. 10.1016/j.ijrobp.2010.01.027, 20605363.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.80
, pp. 119-125
-
-
Sudo, K.1
Yamaguchi, T.2
Ishihara, T.3
Nakamura, K.4
Hara, T.5
Denda, T.6
Tawada, K.7
Imagumbai, T.8
Araki, H.9
Sakai, M.10
Hatano, K.11
Kawakami, H.12
Uno, T.13
Ito, H.14
Yokosuka, O.15
-
8
-
-
84871391740
-
A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer
-
10.1016/j.ijrobp.2012.03.059, 22677367
-
Ikeda M, Ioka T, Ito Y, Yonemoto N, Nagase M, Yamao K, Miyakawa H, Ishii H, Furuse J, Sato K, Sato T, Okusaka T. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2013, 85:163-169. 10.1016/j.ijrobp.2012.03.059, 22677367.
-
(2013)
Int J Radiat Oncol Biol Phys
, vol.85
, pp. 163-169
-
-
Ikeda, M.1
Ioka, T.2
Ito, Y.3
Yonemoto, N.4
Nagase, M.5
Yamao, K.6
Miyakawa, H.7
Ishii, H.8
Furuse, J.9
Sato, K.10
Sato, T.11
Okusaka, T.12
-
9
-
-
58149467927
-
Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations
-
Manak E, Merkel S, Klein P, Papadopoulos T, Bautz WA, Baum U. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations. Abdom Imag 2009, 34:75-80.
-
(2009)
Abdom Imag
, vol.34
, pp. 75-80
-
-
Manak, E.1
Merkel, S.2
Klein, P.3
Papadopoulos, T.4
Bautz, W.A.5
Baum, U.6
-
10
-
-
0345505656
-
Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma
-
10.1002/cncr.11165, 12599244
-
Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M, Nakagohri T, Inoue K, Ogino T, Ikeda H, Maru Y, Yoshino M. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer 2003, 97:1346-1352. 10.1002/cncr.11165, 12599244.
-
(2003)
Cancer
, vol.97
, pp. 1346-1352
-
-
Furuse, J.1
Kinoshita, T.2
Kawashima, M.3
Ishii, H.4
Nagase, M.5
Konishi, M.6
Nakagohri, T.7
Inoue, K.8
Ogino, T.9
Ikeda, H.10
Maru, Y.11
Yoshino, M.12
-
11
-
-
68049128277
-
Staging for locally advanced pancreatic cancer
-
10.1016/j.ejso.2009.01.013, 19246172
-
Morak MJ, Hermans JJ, Smeenk HG, Renders WM, Nuyttens JJ, Kazemier G, van Eijck CH. Staging for locally advanced pancreatic cancer. Eur J Surg Oncol 2009, 35:963-968. 10.1016/j.ejso.2009.01.013, 19246172.
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 963-968
-
-
Morak, M.J.1
Hermans, J.J.2
Smeenk, H.G.3
Renders, W.M.4
Nuyttens, J.J.5
Kazemier, G.6
van Eijck, C.H.7
-
12
-
-
34250829023
-
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
-
10.1002/cncr.22735, 17538975
-
Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 2007, 110:47-55. 10.1002/cncr.22735, 17538975.
-
(2007)
Cancer
, vol.110
, pp. 47-55
-
-
Krishnan, S.1
Rana, V.2
Janjan, N.A.3
Varadhachary, G.R.4
Abbruzzese, J.L.5
Das, P.6
Delclos, M.E.7
Gould, M.S.8
Evans, D.B.9
Wolff, R.A.10
Crane, C.H.11
-
13
-
-
65549143674
-
Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review
-
10.1200/JCO.2008.19.7921, 19307501
-
Huguet F, Girard N, Guerche CS-E, Hennequin C, Mornex F, Azria D. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review. J Clin Oncol 2009, 27:2269-2277. 10.1200/JCO.2008.19.7921, 19307501.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2269-2277
-
-
Huguet, F.1
Girard, N.2
Guerche, C.S.-E.3
Hennequin, C.4
Mornex, F.5
Azria, D.6
-
14
-
-
0030938059
-
Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma
-
10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0, 9118032
-
Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997, 79:1516-1520. 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0, 9118032.
-
(1997)
Cancer
, vol.79
, pp. 1516-1520
-
-
Ishii, H.1
Okada, S.2
Tokuuye, K.3
Nose, H.4
Okusaka, T.5
Yoshimori, M.6
Nagahama, H.7
Sumi, M.8
Kagami, Y.9
Ikeda, H.10
-
15
-
-
77953413803
-
Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506
-
10.1093/jjco/hyq011, 20185458, JCOG Gastrointestinal Oncology Study Group
-
Ishii H, Furuse J, Boku N, Okusaka T, Ikeda M, Ohkawa S, Fukutomi A, Hamamoto Y, Nakamura K, Fukuda H, . JCOG Gastrointestinal Oncology Study Group Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506. Jpn J Clin Oncol 2010, 40:573-579. 10.1093/jjco/hyq011, 20185458, JCOG Gastrointestinal Oncology Study Group.
-
(2010)
Jpn J Clin Oncol
, vol.40
, pp. 573-579
-
-
Ishii, H.1
Furuse, J.2
Boku, N.3
Okusaka, T.4
Ikeda, M.5
Ohkawa, S.6
Fukutomi, A.7
Hamamoto, Y.8
Nakamura, K.9
Fukuda, H.10
-
16
-
-
79960209335
-
Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study
-
Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Chen J, Mizumoto K, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Cheng A, Okusaka T. Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer (PC) in Japan and Taiwan: GEST study. J Clin Oncol 2011, 29:257s.
-
(2011)
J Clin Oncol
, vol.29
-
-
Ioka, T.1
Ikeda, M.2
Ohkawa, S.3
Yanagimoto, H.4
Fukutomi, A.5
Sugimori, K.6
Baba, H.7
Yamao, K.8
Shimamura, T.9
Chen, J.10
Mizumoto, K.11
Furuse, J.12
Funakoshi, A.13
Hatori, T.14
Yamaguchi, T.15
Egawa, S.16
Sato, A.17
Ohashi, Y.18
Cheng, A.19
Okusaka, T.20
more..
-
17
-
-
77954771381
-
Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer
-
Nio K, Ueno H, Okusaka T, Morizane C, Hagihara A, Kondo S, Mayahara H, Ito Y. Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer. J Clin Oncol 2010, 28(Suppl):e14504.
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL
-
-
Nio, K.1
Ueno, H.2
Okusaka, T.3
Morizane, C.4
Hagihara, A.5
Kondo, S.6
Mayahara, H.7
Ito, Y.8
-
18
-
-
57849117384
-
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
-
10.1016/j.ejca.2008.10.026, 19097774
-
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247. 10.1016/j.ejca.2008.10.026, 19097774.
-
(2009)
Eur J Cancer
, vol.45
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
Schwartz, L.H.4
Sargent, D.5
Ford, R.6
Dancey, J.7
Arbuck, S.8
Gwyther, S.9
Mooney, M.10
Rubinstein, L.11
Shankar, L.12
Dodd, L.13
Kaplan, R.14
Lacombe, D.15
Verweij, J.16
-
19
-
-
22144444482
-
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: eastern cooperative oncology group study E8282
-
10.1016/j.ijrobp.2004.12.074, 16029791, Eastern Cooperative Oncology Group
-
Cohen SJ, Dobelbower R, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG, Haller DG, . Eastern Cooperative Oncology Group A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: eastern cooperative oncology group study E8282. Int J Radiat Oncol Biol Phys 2005, 62:1345-1350. 10.1016/j.ijrobp.2004.12.074, 16029791, Eastern Cooperative Oncology Group.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 1345-1350
-
-
Cohen, S.J.1
Dobelbower, R.2
Lipsitz, S.3
Catalano, P.J.4
Sischy, B.5
Smith, T.J.6
Haller, D.G.7
Haller, D.G.8
-
20
-
-
80755143456
-
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial
-
10.1200/JCO.2011.34.8904, 3525836, 21969502
-
Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, Flynn P, Ramanathan RK, Crane CH, Alberts SR, Benson AB. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J Clin Oncol 2011, 29:4105-4111. 10.1200/JCO.2011.34.8904, 3525836, 21969502.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4105-4111
-
-
Loehrer, P.J.1
Feng, Y.2
Cardenes, H.3
Wagner, L.4
Brell, J.M.5
Cella, D.6
Flynn, P.7
Ramanathan, R.K.8
Crane, C.H.9
Alberts, S.R.10
Benson, A.B.11
-
21
-
-
80053372502
-
A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier oncology group study
-
10.1097/COC.0b013e3181e9c103, 20881474
-
Cardenes HR, Moore AM, Johnson CS, Yu M, Helft P, Chiorean EG, Vinson J, Howard TJ, Stephens AW, Tai DF, Loehrer PJ. A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier oncology group study. Am J Clin Oncol 2011, 34:460-465. 10.1097/COC.0b013e3181e9c103, 20881474.
-
(2011)
Am J Clin Oncol
, vol.34
, pp. 460-465
-
-
Cardenes, H.R.1
Moore, A.M.2
Johnson, C.S.3
Yu, M.4
Helft, P.5
Chiorean, E.G.6
Vinson, J.7
Howard, T.J.8
Stephens, A.W.9
Tai, D.F.10
Loehrer, P.J.11
-
22
-
-
33749169384
-
S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU
-
Nakata E, Fukushima M, Takai Y, Nemoto K, Ogawa Y, Nomiya T, Nakamura Y, Milas L, Yamada S. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU. Oncol Rep 2006, 16:465-471.
-
(2006)
Oncol Rep
, vol.16
, pp. 465-471
-
-
Nakata, E.1
Fukushima, M.2
Takai, Y.3
Nemoto, K.4
Ogawa, Y.5
Nomiya, T.6
Nakamura, Y.7
Milas, L.8
Yamada, S.9
-
23
-
-
38049048176
-
A late phase II study of S-1 for metastatic pancreatic cancer
-
10.1007/s00280-007-0514-8, 17520253
-
Okusaka T, Funakoshi A, Furuse J, Boku N, Yamao K, Ohkawa S, Saito H. A late phase II study of S-1 for metastatic pancreatic cancer. Cancer Chemother Pharmacol 2008, 61:615-621. 10.1007/s00280-007-0514-8, 17520253.
-
(2008)
Cancer Chemother Pharmacol
, vol.61
, pp. 615-621
-
-
Okusaka, T.1
Funakoshi, A.2
Furuse, J.3
Boku, N.4
Yamao, K.5
Ohkawa, S.6
Saito, H.7
-
24
-
-
57149136453
-
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
-
10.1007/s00280-008-0741-7, 18398614
-
Morizane C, Okusaka T, Furuse J, Ishii H, Ueno H, Ikeda M, Nakachi K, Najima M, Ogura T, Suzuki E. A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer. Cancer Chemother Pharmacol 2009, 63:313-319. 10.1007/s00280-008-0741-7, 18398614.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 313-319
-
-
Morizane, C.1
Okusaka, T.2
Furuse, J.3
Ishii, H.4
Ueno, H.5
Ikeda, M.6
Nakachi, K.7
Najima, M.8
Ogura, T.9
Suzuki, E.10
-
25
-
-
33846908072
-
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies
-
10.1200/JCO.2006.07.5663, 17235048
-
Huguet F, André T, Hammel P, Artru P, Balosso J, Selle F, Deniaud-Alexandre E, Ruszniewski P, Touboul E, Labianca R, de Gramont A, Louvet C. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 2007, 25:326-331. 10.1200/JCO.2006.07.5663, 17235048.
-
(2007)
J Clin Oncol
, vol.25
, pp. 326-331
-
-
Huguet, F.1
André, T.2
Hammel, P.3
Artru, P.4
Balosso, J.5
Selle, F.6
Deniaud-Alexandre, E.7
Ruszniewski, P.8
Touboul, E.9
Labianca, R.10
de Gramont, A.11
Louvet, C.12
-
26
-
-
41949089709
-
Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a groupe coordinateur multidisciplinaire en O
-
10.1200/JCO.2007.12.8223, 18309942
-
Moureau-Zabotto L, Phélip JM, Afchain P, Mineur L, André T, Vendrely V, Lledo G, Dupuis O, Huguet F, Touboul E, Balosso J, Louvet C. Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a groupe coordinateur multidisciplinaire en O. J Clin Oncol 2008, 26:1080-1085. 10.1200/JCO.2007.12.8223, 18309942.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1080-1085
-
-
Moureau-Zabotto, L.1
Phélip, J.M.2
Afchain, P.3
Mineur, L.4
André, T.5
Vendrely, V.6
Lledo, G.7
Dupuis, O.8
Huguet, F.9
Touboul, E.10
Balosso, J.11
Louvet, C.12
-
27
-
-
77954665310
-
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
-
10.1007/s00280-009-1193-4, 19967537
-
Nakachi K, Furuse J, Kinoshita T, Kawashima M, Ishii H, Ikeda M, Mitsunaga S, Shimizu S. A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer Chemother Pharmacol 2010, 66:527-534. 10.1007/s00280-009-1193-4, 19967537.
-
(2010)
Cancer Chemother Pharmacol
, vol.66
, pp. 527-534
-
-
Nakachi, K.1
Furuse, J.2
Kinoshita, T.3
Kawashima, M.4
Ishii, H.5
Ikeda, M.6
Mitsunaga, S.7
Shimizu, S.8
-
28
-
-
80051613675
-
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4 (Dpc4) immunostaining with pattern of disease progression
-
10.1200/JCO.2010.33.8038, 3157965, 21709185
-
Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4 (Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 2011, 29:3037-3043. 10.1200/JCO.2010.33.8038, 3157965, 21709185.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3037-3043
-
-
Crane, C.H.1
Varadhachary, G.R.2
Yordy, J.S.3
Staerkel, G.A.4
Javle, M.M.5
Safran, H.6
Haque, W.7
Hobbs, B.D.8
Krishnan, S.9
Fleming, J.B.10
Das, P.11
Lee, J.E.12
Abbruzzese, J.L.13
Wolff, R.A.14
-
29
-
-
0031874821
-
Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer
-
Okusaka T, Okada S, Sato T, Wakasugi H, Saisho H, Furuse J, Ishikawa O, Matsuno S, Yokoyama S. Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer. Hepatogastroenterology 1998, 45:867-872.
-
(1998)
Hepatogastroenterology
, vol.45
, pp. 867-872
-
-
Okusaka, T.1
Okada, S.2
Sato, T.3
Wakasugi, H.4
Saisho, H.5
Furuse, J.6
Ishikawa, O.7
Matsuno, S.8
Yokoyama, S.9
-
30
-
-
61349202170
-
CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy
-
10.1016/j.ijrobp.2008.06.1483, 18760544
-
Koom WS, Seong J, Kim YB, Pyun HO, Song SY. CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009, 73:1148-1154. 10.1016/j.ijrobp.2008.06.1483, 18760544.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 1148-1154
-
-
Koom, W.S.1
Seong, J.2
Kim, Y.B.3
Pyun, H.O.4
Song, S.Y.5
|